LTRN Lantern Pharma Inc
Company Analysis
Latest News
🔴 Lantern Pharma is trading 6% down in after-hours trading
Lantern Pharma is trading at $0.60 (-5.96%); broader risk-off sentiment may have contributed to the October 22 after-hours move, though no direct...
🟢 Lantern Pharma is trading 9.5% up in pre-market amid biotech-sector strength
Lantern Pharma is trading 9.54% higher pre-market at $0.75, with biotech-sector strength possibly supporting shares; no direct catalyst is confirmed. - Shares...
🟢 Lantern Pharma is trading 5.2% up today with broader biotech strength a possible factor
Lantern Pharma is trading up 5.2% at $0.69 as of 10:00 a.m. ET on October 21, 2026, with broader biotech strength a possible supporting factor; no...
🟢 Lantern Pharma is trading 6.6% up in pre-market
Lantern Pharma is trading 6.6% up at $0.70 in pre-market, with no company-specific announcement identified to explain the October 21 move. - The company’s...
🟢 Lantern Pharma is trading 6.64% up in after-hours trading
Lantern Pharma is trading 6.64% higher at $0.70 after-hours, with no confirmed company-specific catalyst identified. - The October 20 regular session closed...
🟢 Lantern Pharma is trading 12.3% up
Lantern Pharma is trading at $0.72, up 12.32%, with no confirmed company-specific catalyst identified for the move. - No new company-specific announcement was...
🔴 Lantern Pharma is trading 5% down
Lantern Pharma is trading at $0.61, down 5.44% during the October 20, 2026 regular session; no company-specific explanation for the decline is confirmed. -...
🔴 Lantern Pharma is trading 5.66% down in pre-market — no company-specific explanation confirmed
Lantern Pharma is trading at $0.60, down 5.66% in pre-market, with no confirmed company-specific explanation for the decline. - No October 19 or October 20...
🟢 Lantern Pharma is trading 18.5% up in pre-market with no confirmed company announcement
Lantern Pharma is trading at $0.76, up 18.51%, with no confirmed company announcement explaining the sharp pre-market gain. - The latest notable...
🔴 Lantern Pharma is trading 6.3% down with no clear company-specific catalyst identified
Lantern Pharma is trading 6.3% lower at $0.63 on October 16, 2026, with no clear company-specific catalyst identified. - Major U.S. indexes are lower, and...
🟢 Lantern Pharma is trading 10% up; catalyst remains unclear
Lantern Pharma is trading at $0.73, up +10.21%, with the catalyst unclear as of 9:50 a.m. ET on October 16, 2026. - No clear company-specific announcement...
🔴 Lantern Pharma is trading 5.6% down as hotter-than-expected inflation weighs on growth stocks
Lantern Pharma is trading 5.6% down at $0.67, with broad market pressure after hotter-than-expected inflation data the likeliest explanation. - Major indexes...
🔴 Lantern Pharma is trading 5% down today with no clear company-specific catalyst identified
Lantern Pharma is trading 5.02% down at $0.70 on October 13, 2026, with no clear company-specific announcement identified to explain the decline. - Its latest...
🔴 Lantern Pharma is trading 10.2% down amid an unexplained stock-specific move
Lantern Pharma is trading 10.16% down at $0.73 on October 12, 2026, in an unexplained stock-specific move. - No clear company-specific announcement explaining...
🔴 Lantern Pharma is trading 6.5% down with no identified catalyst
Lantern Pharma is trading 6.48% down at $0.76 on October 12, 2026, with no clear company-specific catalyst identified. - The latest company announcements were...
🔴 Lantern Pharma is trading 5% down in pre-market
Lantern Pharma is trading at $0.77, with a -5.22% change in the October 12 pre-market; no clear company-specific catalyst was identified. - The company’s...
🔴 Lantern Pharma is trading 6% down
Lantern Pharma is trading at $0.78, down 6.01% at 10:45 a.m. ET on October 9; no clear company-specific catalyst for the decline has been identified. - The...
🔴 Lantern Pharma is trading 7.4% down with no clear company-specific catalyst
Lantern Pharma is trading 7.4% lower at $0.84, with no company-specific news explaining the decline. - Lantern Pharma announced a ThinkEquity Conference...
🟢 Lantern Pharma is trading 5% up in pre-market after Taiwan approvals advanced HARMONIC Part 2
Lantern Pharma is trading 5.49% up at $0.96 in pre-market, with trial advancement a plausible catalyst. - On October 7, Taiwan regulators and an institutional...
🔴 Lantern Pharma is trading 5.61% down on October 7, 2026 as biotech stocks faced pressure
Lantern Pharma is trading at $0.90, down 5.61%, amid biotech-sector weakness. - No October 7, 2026 company-specific announcement was identified; the latest...